BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11336350)

  • 1. Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.
    Beyer U; Rothern-Rutishauser B; Unger C; Wunderli-Allenspach H; Kratz F
    Pharm Res; 2001 Jan; 18(1):29-38. PubMed ID: 11336350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.
    Kratz F; Beyer U; Roth T; Tarasova N; Collery P; Lechenault F; Cazabat A; Schumacher P; Unger C; Falken U
    J Pharm Sci; 1998 Mar; 87(3):338-46. PubMed ID: 9523988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin.
    Seib FP; Jones AT; Duncan R
    J Drug Target; 2006 Jul; 14(6):375-90. PubMed ID: 17092838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.
    Hovorka O; Etrych T; Subr V; Strohalm J; Ulbrich K; Ríhová B
    J Drug Target; 2006 Jul; 14(6):391-403. PubMed ID: 17092839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the intracellular fate of free and polymer-bound doxorubicin.
    Hovorka O; St'astný M; Etrych T; Subr V; Strohalm J; Ulbrich K; Ríhová B
    J Control Release; 2002 Apr; 80(1-3):101-17. PubMed ID: 11943391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines.
    Serpe L; Guido M; Canaparo R; Muntoni E; Cavalli R; Panzanelli P; Della Pepal C; Bargoni A; Mauro A; Gasco MR; Eandi M; Zara GP
    J Nanosci Nanotechnol; 2006; 6(9-10):3062-9. PubMed ID: 17048519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging.
    Seynhaeve ALB; Dicheva BM; Hoving S; Koning GA; Ten Hagen TLM
    J Control Release; 2013 Nov; 172(1):330-340. PubMed ID: 24012486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model.
    Kratz F; Roth T; Fichiner I; Schumacher P; Fiebig HH; Unger C
    J Drug Target; 2000; 8(5):305-18. PubMed ID: 11328658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysis.
    Huxham IM; Barlow AL; Lewis AD; Plumb J; Mairs RJ; Gaze MN; Workman P
    Int J Cancer; 1994 Oct; 59(1):94-102. PubMed ID: 7927910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action and spectrum of cell lines sensitive to a doxorubicin-transferrin conjugate.
    Lai BT; Gao JP; Lanks KW
    Cancer Chemother Pharmacol; 1998; 41(2):155-60. PubMed ID: 9443629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
    Ali-Seyed M; Bhuvaneswari R; Soo KC; Olivo M
    Int J Oncol; 2011 Oct; 39(4):821-31. PubMed ID: 21725591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: liposomal carrier for enhanced drug delivery.
    Ho JA; Fan NC; Jou AF; Wu LC; Sun TP
    Talanta; 2012 Sep; 99():683-8. PubMed ID: 22967611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
    Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
    Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular localization of the radiation enhancer motexafin gadolinium using interferometric Fourier fluorescence microscopy.
    Woodburn KW
    J Pharmacol Exp Ther; 2001 Jun; 297(3):888-94. PubMed ID: 11356908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular trafficking of a pH-responsive drug metal complex.
    Kheirolomoom A; Ingham ES; Commisso J; Abushaban N; Ferrara KW
    J Control Release; 2016 Dec; 243():232-242. PubMed ID: 27746275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin.
    Veldman RJ; Koning GA; van Hell A; Zerp S; Vink SR; Storm G; Verheij M; van Blitterswijk WJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):704-10. PubMed ID: 16040815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
    Harasym TO; Cullis PR; Bally MB
    Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
    Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.